Growing Prevalence of Irritable Bowel Syndrome is expected to Drive Growth of the Global Irritable Bowel Syndrome Treatment Market

 

Irritable Bowel Syndrome Treatment Market
Irritable Bowel Syndrome Treatment Market

Irritable bowel syndrome is a digestive system illness that causes stomach pain and changes in bowel habits. It impairs the normal motility of intestinal muscular linings in the digestive tract. The syndrome is classified as mild or severe irritable bowel syndrome based on the severity of the symptoms. Cramping, abdominal pain, bloating and gas, mucus in the stool, constipation, and diarrhoea are among the symptoms.

The rising prevalence of irritable bowel syndrome (IBS) is likely to fuel Irritable Bowel Syndrome Treatment Market expansion over the forecast period. For example, according to an article published in January 2021 by Cureus, an open access general medical journal, a cross-section study was conducted in the internal medicine unit of a tertiary care hospital in multiple cities of Pakistan from June 2019 to August 2019, to determine the prevalence of IBS in a healthy population and the characteristics of symptoms. According to the findings, the prevalence of IBS in the general population was 33.2%.

Increasing R&D initiatives by key market players for the development of irritable bowel syndrome medications are projected to fuel market expansion over the forecast period. For example, on June 9, 2022, Ferring B.V. announced a strategic collaboration with I-MAB Biopharma Co., Ltd., an innovation-driven global biopharma company, to further develop olamkicept, a selective interleukin-6 (IL-6) trans-signaling inhibitor for inflammatory bowel disease (IBD) and related inflammatory conditions.

Comments

Popular posts from this blog

The Role of the Foodservice Industry in Driving the French Fries Market

Market Share and Revenue Analysis of the Microdermabrasion Devices Market

The Growing Demand for Healthcare Staffing Market: Trends and Opportunities